Pricing Pharmaceuticals
Martin delves into the complexities of drug pricing, emphasizing the balance between production costs and the value to patients. He discusses utility theory, arguing that prices should reflect the cost savings from avoiding expensive medical procedures. Highlighting the risks involved in drug development, he asserts that pharmaceutical companies need to account for potential failures while still aiming for profitable returns.In this clip
From this podcast
My First Million
Martin Shkreli Reveals How He Made His First $100 Million (#445)
Related Questions